|
1
|
Chen AY, Jemal A and Ward EM: Increasing
incidence of differentiated thyroid cancer in the United States,
1988–2005. Cancer. 115:3801–3807. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pellegriti G, Frasca F, Regalbuto C,
Squatrito S and Vigneri R: Worldwide increasing incidence of
thyroid cancer: Update on epidemiology and risk factors. J Cancer
Epidemiol. 2013:9652122013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Huang P, Mao LF, Zhang ZP, Lv WW, Feng XP,
Liao HJ, Dong C, Kaluba B, Tang XF and Chang S: Down-Regulated
miR-125a-5p promotes the reprogramming of glucose metabolism and
cell malignancy by increasing levels of CD147 in thyroid cancer.
Thyroid. 28:613–623. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Choi D, Ramu S, Park E, Jung E, Yang S,
Jung W, Choi I, Lee S, Kim KE, Seong YJ, et al: Aberrant activation
of notch signaling inhibits PROX1 activity to enhance the malignant
behavior of thyroid cancer cells. Cancer Res. 76:582–593. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Prensner JR and Chinnaiyan AM: The
emergence of lncRNAs in cancer biology. Cancer Discov. 1:391–407.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang F, Yuan JH, Wang SB, Yang F, Yuan SX,
Ye C, Yang N, Zhou WP, Li WL, Li W and Sun SH: Oncofetal long
noncoding RNA PVT1 promotes proliferation and stem cell-like
property of hepatocellular carcinoma cells by stabilizing NOP2.
Hepatology. 60:1278–1290. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cao C, Sun J, Zhang D, Guo X, Xie L, Li X,
Wu D and Liu L: The long intergenic noncoding RNA UFC1, a target of
MicroRNA 34a, interacts with the mRNA stabilizing protein HuR to
increase levels of β-catenin in HCC cells. Gastroenterology.
148:415–426. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Engreitz JM, Pandya-Jones A, McDonel P,
Shishkin A, Sirokman K, Surka C, Kadri S, Xing J, Goren A, Lander
ES, et al: The Xist lncRNA exploits three-dimensional genome
architecture to spread across the X chromosome. Science.
341:12379732013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang F, Deng X, Ma W, Berletch JB, Rabaia
N, Wei G, Moore JM, Filippova GN, Xu J, Liu Y, et al: The lncRNA
Firre anchors the inactive X chromosome to the nucleolus by binding
CTCF and maintains H3K27me3 methylation. Genome Biol. 16:522015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yoon JH, Abdelmohsen K and Gorospe M:
Posttranscriptional gene regulation by long noncoding RNA. J Mol
Biol. 425:3723–3730. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun W, Lan X, Zhang H, Wang Z, Dong W, He
L, Zhang T, Zhang P, Liu J and Qin Y: NEAT1_2 functions as a
competing endogenous RNA to regulate ATAD2 expression by sponging
microRNA-106b-5p in papillary thyroid cancer. Cell Death Dis.
9:3802018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen C, Zhou L, Wang H, Chen J, Li W, Liu
W, Shen M, Liu H and Fu X: Long noncoding RNA CNALPTC1 promotes
cell proliferation and migration of papillary thyroid cancer via
sponging miR-30 family. Am J Cancer Res. 8:192–206. 2018.PubMed/NCBI
|
|
13
|
Zhang R, Hardin H, Chen J, Guo Z and Lloyd
RV: Non-coding RNAs in thyroid cancer. Endocr Pathol. 27:12–20.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang G, Lu X and Yuan L: LncRNA: A link
between RNA and cancer. Biochim Biophys Acta. 1839:1097–1109. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang JK, Ma L, Song WH, Lu BY, Huang YB,
Dong HM, Ma XK, Zhu ZZ and Zhou R: LncRNA-MALAT1 Promotes
angiogenesis of thyroid cancer by modulating tumor-associated
macrophage FGF2 protein secretion. J Cell Biochem. 118:4821–4830.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li Q, Li H, Zhang L, Zhang C, Yan W and
Wang C: Identification of novel long non-coding RNA biomarkers for
prognosis prediction of papillary thyroid cancer. Oncotarget.
8:46136–46144. 2017.PubMed/NCBI
|
|
17
|
Guo LJ, Zhang S, Gao B, Jiang Y, Zhang XH,
Tian WG, Hao S, Zhao JJ, Zhang G, Hu CY, et al: Low expression of
long non-coding RNA GAS5 is associated with poor prognosis of
patients with thyroid cancer. Exp Mol Pathol. 102:500–504. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
She K, Huang J, Zhou H, Huang T, Chen G
and He J: lncRNA-SNHG7 promotes the proliferation, migration and
invasion and inhibits apoptosis of lung cancer cells by enhancing
the FAIM2 expression. Oncol Rep. 36:2673–2680. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang MW, Liu J, Liu Q, Xu QH, Li TF, Jin S
and Xia TS: LncRNA SNHG7 promotes the proliferation and inhibits
apoptosis of gastric cancer cells by repressing the P15 and P16
expression. Eur Rev Med Pharmacol Sci. 21:4613–4622.
2017.PubMed/NCBI
|
|
20
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC cancer staging manual7th. NY:
Springer; 2010
|
|
23
|
Barros-Filho MC, Marchi FA, Pinto CA,
Rogatto SR and Kowalski LP: High diagnostic accuracy based on
CLDN10, HMGA2, and LAMB3 transcripts in papillary thyroid
carcinoma. J Clin Endocrinol Metab. 100:E890–E899. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tomas G, Tarabichi M, Gacquer D, Hebrant
A, Dom G, Dumont JE, Keutgen X, Fahey TR, Maenhaut C and Detours V:
A general method to derive robust organ-specific gene
expression-based differentiation indices: Application to thyroid
cancer diagnostic. Oncogene. 31:4490–4498. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dom G, Tarabichi M, Unger K, Thomas G,
Oczko-Wojciechowska M, Bogdanova T, Jarzab B, Dumont JE, Detours V
and Maenhaut C: A gene expression signature distinguishes normal
tissues of sporadic and radiation-induced papillary thyroid
carcinomas. Br J Cancer. 107:994–1000. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Szklarczyk D, Gable AL, Lyon D, Junge A,
Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork
P, et al: STRING v11: Protein-protein association networks with
increased coverage, supporting functional discovery in genome-wide
experimental datasets. Nucleic Acids Res. 47:D607–D613. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bader GD and Hogue CW: An automated method
for finding molecular complexes in large protein interaction
networks. Bmc Bioinformatics. 4:22003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Williams GH and Stoeber K: The cell cycle
and cancer. J Pathol. 226:352–364. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kastan MB and Bartek J: Cell-cycle
checkpoints and cancer. Nature. 432:316–323. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Misawa A, Takayama KI and Inoue S: Long
non-coding RNAs and prostate cancer. Cancer Sci. 108:2107–2114.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wan X, Huang W, Yang S, Zhang Y, Pu H, Fu
F, Huang Y, Wu H, Li T and Li Y: Identification of
androgen-responsive lncRNAs as diagnostic and prognostic markers
for prostate cancer. Oncotarget. 7:60503–60518. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kumar M, DeVaux RS and Herschkowitz JI:
Molecular and cellular changes in breast cancer and new roles of
lncRNAs in breast cancer initiation and progression. Prog Mol Biol
Transl Sci. 144:563–586. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li T, Liu Y, Xiao H and Xu G: Long
non-coding RNA TUG1 promotes cell proliferation and metastasis in
human breast cancer. Breast Cancer. 24:535–543. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Park SM, Choi EY, Bae DH, Sohn HA, Kim SY
and Kim YJ: The LncRNA EPEL promotes lung cancer cell proliferation
through E2F target activation. Cell Physiol Biochem. 45:1270–1283.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tao H, Yang JJ, Zhou X, Deng ZY, Shi KH
and Li J: Emerging role of long noncoding RNAs in lung cancer:
Current status and future prospects. Respir Med. 110:12–19. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kim D, Lee WK, Jeong S, Seol MY, Kim H,
Kim KS, Lee EJ, Lee J and Jo YS: Upregulation of long noncoding RNA
LOC100507661 promotes tumor aggressiveness in thyroid cancer. Mol
Cell Endocrinol. 431:36–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhou Q, Chen J, Feng J and Wang J: Long
noncoding RNA PVT1 modulates thyroid cancer cell proliferation by
recruiting EZH2 and regulating thyroid-stimulating hormone receptor
(TSHR). Tumour Biol. 37:3105–3113. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xu B, Shao Q, Xie K, Zhang Y, Dong T, Xia
Y and Tang W: The long non-coding RNA ENST00000537266 and
ENST00000426615 influence papillary thyroid cancer cell
proliferation and motility. Cell Physiol Biochem. 38:368–378. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu L, Yang J, Zhu X, Li D, Lv Z and Zhang
X: Long noncoding RNA H19 competitively binds miR-17-5p to regulate
YES1 expression in thyroid cancer. FEBS J. 283:2326–2339. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xu LJ, Yu XJ, Wei B, Hui HX, Sun Y, Dai J
and Chen XF: LncRNA SNHG7 promotes the proliferation of esophageal
cancer cells and inhibits its apoptosis. Eur Rev Med Pharmacol Sci.
22:2653–2661. 2018.PubMed/NCBI
|
|
42
|
Qi H, Wen B, Wu Q, Cheng W, Lou J, Wei J,
Huang J, Yao X and Weng G: Long noncoding RNA SNHG7 accelerates
prostate cancer proliferation and cycle progression through cyclin
D1 by sponging miR-503. Biomed Pharmacother. 102:326–332. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ren J, Yang Y, Xue J, Xi Z, Hu L, Pan SJ
and Sun Q: Long noncoding RNA SNHG7 promotes the progression and
growth of glioblastoma via inhibition of miR-5095. Biochem Biophys
Res Commun. 496:712–718. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
She K, Yan H, Huang J, Zhou H and He J:
miR-193b availability is antagonized by LncRNA-SNHG7 for
FAIM2-induced tumour progression in non-small cell lung cancer.
Cell Prolif. Nov 12–2017.(Epub ahead of print). doi:
10.1111/cpr.12406. PubMed/NCBI
|
|
45
|
Chen W, Zhang X, Li J, Huang S, Xiang S,
Hu X and Liu C: Comprehensive analysis of coding-lncRNA gene
co-expression network uncovers conserved functional lncRNAs in
zebrafish. Bmc Genomics. 19 (Suppl 2):S1122018. View Article : Google Scholar
|
